Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shingo Dan

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Pharmacology Research & Perspectives|January 25, 2017
A novel thiophene-3-carboxamide analog of annonaceous acetogenin exhibits antitumor activity via inhibition of mitochondrial complex IAkinobu Akatsuka, Naoto Kojima, Mutsumi Okamura, et al.
Bioscience, Biotechnology, and Biochemistry|February 12, 2021
Effects of side chain length of 10-methyl-aplog-1, a simplified analog of debromoaplysiatoxin, on PKC binding, anti-proliferative, and pro-inflammatory activitiesAtsuko Gonda, Koji Takada, Ryo C Yanagita, et al.
Journal of Medicinal Chemistry|December 11, 2012
Total synthesis of AMF-26, an antitumor agent for inhibition of the Golgi system, targeting ADP-ribosylation factor 1Isamu Shiina, Yuma Umezaki, Yoshimi Ohashi, et al.
Chemical & Pharmaceutical Bulletin|October 4, 2021
Structure-Activity Relationships of Thiophene Carboxamide Annonaceous Acetogenin Analogs: Shortening the Alkyl Chain in the Tail Part Significantly Affects Their Growth Inhibitory Activity against Human Cancer Cell LinesKaito Ohta, Akinobu Akatsuka, Shingo Dan, et al.
Cancer Science|November 17, 2022
Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand breakDoudou Zhang, Takashi Shimokawa, Qianqian Guo, et al.
Cancers|August 29, 2024
Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal CancerMitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, et al.
Chemical & Pharmaceutical Bulletin|November 3, 2022
Synthesis of Acetogenin Analogs Comprising Pyrimidine Moieties Linked by Amine Bonds and Their Inhibitory Activity against Human Cancer Cell LinesHiroyuki Hosomi, Akinobu Akatsuka, Shingo Dan, et al.
Inflammation|March 1, 2014
AS252424, a PI3Kγ inhibitor, downregulates inflammatory responsiveness in mouse bone marrow-derived mast cellsMeihua Jin, Qianxiang Zhou, Eunkyung Lee, et al.
Biological & Pharmaceutical Bulletin|April 12, 2013
Search for novel anti-tumor agents from ridaifens using JFCR39, a panel of human cancer cell linesWen-zhi Guo, Yanwen Wang, Eri Umeda, et al.
Molecular Cancer Therapeutics|March 16, 2005
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arraysNoriyuki Nakatsu, Yoko Yoshida, Kanami Yamazaki, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Pharmacology Research & Perspectives|January 25, 2017
A novel thiophene-3-carboxamide analog of annonaceous acetogenin exhibits antitumor activity via inhibition of mitochondrial complex IAkinobu Akatsuka, Naoto Kojima, Mutsumi Okamura, et al.
Bioscience, Biotechnology, and Biochemistry|February 12, 2021
Effects of side chain length of 10-methyl-aplog-1, a simplified analog of debromoaplysiatoxin, on PKC binding, anti-proliferative, and pro-inflammatory activitiesAtsuko Gonda, Koji Takada, Ryo C Yanagita, et al.
Journal of Medicinal Chemistry|December 11, 2012
Total synthesis of AMF-26, an antitumor agent for inhibition of the Golgi system, targeting ADP-ribosylation factor 1Isamu Shiina, Yuma Umezaki, Yoshimi Ohashi, et al.
Chemical & Pharmaceutical Bulletin|October 4, 2021
Structure-Activity Relationships of Thiophene Carboxamide Annonaceous Acetogenin Analogs: Shortening the Alkyl Chain in the Tail Part Significantly Affects Their Growth Inhibitory Activity against Human Cancer Cell LinesKaito Ohta, Akinobu Akatsuka, Shingo Dan, et al.
Cancer Science|November 17, 2022
Discovery of novel DNA-damaging agents through phenotypic screening for DNA double-strand breakDoudou Zhang, Takashi Shimokawa, Qianqian Guo, et al.
Cancers|August 29, 2024
Exploratory Study Identifies Matrix Metalloproteinase-14 and -9 as Potential Biomarkers of Regorafenib Efficacy in Metastatic Colorectal CancerMitsukuni Suenaga, Tetsuo Mashima, Naomi Kawata, et al.
Chemical & Pharmaceutical Bulletin|November 3, 2022
Synthesis of Acetogenin Analogs Comprising Pyrimidine Moieties Linked by Amine Bonds and Their Inhibitory Activity against Human Cancer Cell LinesHiroyuki Hosomi, Akinobu Akatsuka, Shingo Dan, et al.
Inflammation|March 1, 2014
AS252424, a PI3Kγ inhibitor, downregulates inflammatory responsiveness in mouse bone marrow-derived mast cellsMeihua Jin, Qianxiang Zhou, Eunkyung Lee, et al.
Biological & Pharmaceutical Bulletin|April 12, 2013
Search for novel anti-tumor agents from ridaifens using JFCR39, a panel of human cancer cell linesWen-zhi Guo, Yanwen Wang, Eri Umeda, et al.
Molecular Cancer Therapeutics|March 16, 2005
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arraysNoriyuki Nakatsu, Yoko Yoshida, Kanami Yamazaki, et al.
Pageof 9